Neil Solomons

Currently holds a position at Aurinia Pharmaceuticals Inc

Position	Company	Period
Chief Marketing Officer	Aurinia Pharmaceuticals Inc	Sept. 1, 2013 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-03-04	2022-03-02	Aurinia Pharmaceuticals Inc (AUP)	S Sale	72,431 +45.2% 411.47 US$1,964,708	72,431 +45.2%	411.47	US$1,964,708
2021-11-12	2021-11-11	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	81,005 -20.6% 291.85 US$3,203,119	81,005 -20.6%	291.85	US$3,203,119
2021-11-12	2021-11-10	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	35,917 -49.2% 131.94 US$859,390	35,917 -49.2%	131.94	US$859,390
2021-11-12	2021-11-10	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	90,000 -48.1% 31.17 US$2,805,300	90,000 -48.1%	31.17	US$2,805,300
2021-11-12	2021-11-09	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	50,000 -36.4% 30.17 US$1,508,500	50,000 -36.4%	30.17	US$1,508,500
2021-11-03	2021-11-01	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	45,000 -24.7% 31.64 US$1,423,800	45,000 -24.7%	31.64	US$1,423,800
2021-09-14	2021-09-10	Aurinia Pharmaceuticals Inc (AUP)	PlS Planned sale	150,000 -52.2% 19.84 US$2,976,000	150,000 -52.2%	19.84	US$2,976,000
2021-03-15	2021-03-12	Aurinia Pharmaceuticals Inc (AUP)	S Sale	40,000 -17.6% 13.49 US$539,600	40,000 -17.6%	13.49	US$539,600